Michael B. Datto
Affiliations: | Pathology | Duke University, Durham, NC |
Area:
Pathology, Molecular BiologyGoogle:
"Michael Datto"
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Kao C, Powers E, Datto MB, et al. (2020) Tumor mutational burden (TMB) as a predictive biomarker of immune checkpoint blockade (ICB) in metastatic solid tumors. Journal of Clinical Oncology. 38: 80-80 |
| Watson C, Tait S, Soo L, et al. (2020) The prevalence of germline mutations among patients with solid tumors with genomic alterations identified on tumor testing: Results from a tertiary care academic center molecular tumor board. Journal of Clinical Oncology. 38: 1516-1516 |
| Zhu J, Tucker MD, Kao C, et al. (2019) Immune checkpoint inhibitor response in tumors with LRP1B variants. Journal of Clinical Oncology. 37: e14291-e14291 |
| Korkut A, Zaidi S, Kanchi RS, et al. (2018) A Pan-Cancer Analysis Reveals High-Frequency Genetic Alterations in Mediators of Signaling by the TGF-β Superfamily. Cell Systems |
| Korkut A, Zaidi S, Kanchi R, et al. (2018) Abstract 3413: A pan-cancer atlas of genomic, epigenomic and transcriptomic alterations in the TGF-β pathway Cancer Research. 78: 3413-3413 |
| Li MM, Datto M, Duncavage EJ, et al. (2017) Standards and Guidelines for the Interpretation and Reporting of Sequence Variants in Cancer: A Joint Consensus Recommendation of the Association for Molecular Pathology, American Society of Clinical Oncology, and College of American Pathologists. The Journal of Molecular Diagnostics : Jmd. 19: 4-23 |
| Jiang XS, Harrison GP, Datto MB. (2016) Young investigator challenge: Molecular testing in noninvasive follicular thyroid neoplasm with papillary-like nuclear features. Cancer |
| Stevenson M, Christensen J, Shoemaker D, et al. (2014) Tumor acquisition for biomarker research in lung cancer. Cancer Investigation. 32: 291-8 |
| Zessin AS, Randall A, McCall S, et al. (2014) Identification and validation of actionable mutations in solid tumors. Journal of Clinical Oncology. 32 |
| Uronis JM, VanDeusen JB, Datto MB, et al. (2013) A molecular profile of colorectal cancer to guide prognosis and therapy after resection of primary or metastatic disease. Journal of Clinical Oncology. 31: 339-339 |